Delivery Order SPE2DB22D1106-SPE2DB24FDMG2

Award Date 11/17/23
Potential Completion Date 11/20/23
Potential Value $7.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,170.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563807427 - Lidocaine 2% Viscous Solution 100ML, a pharmaceutical product, with a completion date of March 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lidocaine HCl 1% vials. The $1,338.00 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...
This federal contract award is for the delivery of Lidocaine HCL 4% Solution 4ML to the Defense Logistics Agency (DLA), a defense agency. The $3,033.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 16, 2023, with a completion date of November 17, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The delivery order, valued at $1,233.12, is for the supply of 4% Lidocaine Hydrochloride Solution, a medical product used for pain management. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the...
This federal contract award, valued at $1,265.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4% Lidocaine HCL Solution, a pharmaceutical product, with a completion date of May 11, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,234.54 firm fixed price contract is for the supply of Lidocaine HCL 4% Solution 4ML, a medication product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 1% vials, valued at $1,351.13, with a completion date of March 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This federal contract award, valued at $6,214.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,611,525 units of Lidocaine HCL 2% Luer-Jet 5ML, a medical product used in various healthcare applications. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a specific pharmaceutical product - Lidocaine HCL 4% Solution 50ML. The contract award has a ceiling value of $1,095.78 and was issued as a Delivery Order. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
The U.S. Defense Logistics Agency (DLA) awarded a $22,692.39 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of 4% Lidocaine HCL Solution (4 ml). The contract has an ultimate completion date of May 4, 2023. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDMG2
    Delivery Order

This federal contract award, valued at $7,218.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine HCL 4% Solution, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award was made through full and open competition, without any set-aside designation.

Generated 5/12/25, 9:57 AM